| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.04 | 0.5 |